Total Funding
4
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.
About the Company
Cahaba Pharmaceuticals, LLC, a biotech company, focuses on the development of oncology therapeutics and supportive care products for cancer patients. Its products include 1uracil topical ointment, a dihydropyrimidine dehydrogenase inhibitor for the treatment of hand-foot syndrome; and triciribine phosphate monohydrate, a nucleoside analog
inhibition of AKT, a key component of a signaling pathway to promote cancer cell growth and survival, and resistance to chemotherapy and radiotherapy. The company was founded in 2008 and is based in Princeton, New Jersey.
